By Dr. Sanchari Sinha Dutta, Ph.D.Aug 3 2022 Reviewed by Danielle Ellis, B.Sc. In a recent publication Open Forum Infectious Diseases, a team of US-based scientists has described the therapeutic efficacy of a pan-Orthopoxvirus inhibitor, tecovirimat, in patients with monkeypox infection. This drug is currently available under an expanded access investigational new drug protocol for monkeypox. Study: Tecovirimat for...
